The European Herbal Health Products Summit 2026 in Brussels

Organized by the Society for Medicinal Plant and Natural Product Research (GA) and Pharma Deutschland, the summit brought together leading experts from science, industry, and regulatory authorities.

The clear message:
Herbal medicinal products are of significant medical and economic importance – yet they face growing regulatory challenges. Discussions covered HMPC experience, health economic data, the distinction from food supplements, and future perspectives in the OTC sector. The “Market Booths” further showcased innovation potential and the strategic relevance of the European market.

Our key takeaway:
The future of herbal medicinal products will be evidence-based – otherwise, market access and long-term competitiveness will become increasingly challenging.
Regulatory expectations are rising, while solutions must remain economically viable. What is needed is smart, strategic evidence planning. This is precisely where we see our role: at the intersection of scientific rigor, regulatory feasibility, and practical implementation – collaborating closely with our partners.